N-Hydroxy-4-(3-methyl-2-(S)phenyl-butyrylamino)benzamide | |
---|---|
Trade Name | |
Orphan Indication | Meningioma |
USA Market Approval | USA |
USA Designation Date | 2012-01-13 00:00:00 |
Sponsor | Arno Therapeutics, Inc.;200 Route 31 North, Suite 104;Flemington, New Jersey, 08822 |